http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10590153-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76c4f711e3b1f7dd5945edbfc51f0ea8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3873
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
filingDate 2015-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_667ea1bfe244e36f9abf3034e4dd48c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a47a28e714b0111e53c9ecfa168a86fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28e2d8c1e0f3322487aa392d4226e0f9
publicationDate 2020-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10590153-B2
titleOfInvention Process for producing crystalline DTPMP
abstract The present invention relates to crystallizates of the pure aminoalkylenephosphonic acid DTPMP in three crystal polymorphs and to a process for obtaining solid crystalline DTPMP by a preferably one-stage crystallization from an aqueous product mixture comprising DTPMP, wherein the process comprises the following process steps: (a) introducing seed crystals comprising DTPMP into an aqueous crude product comprising DTPMP with a total proportion in the range from 10 to 65 percent by mass up to a suspension density in the range from 1% to 25%; (b) introducing kinetic energy into the aqueous crude product to precipitate a crystallizate containing DTPMP as pure acid with a total content of at least 75% by mass; and (c) removing the crystallizate formed from the aqueous crude product by sedimentation and/or filtration, such that DTPMP is obtained as a solid end product in the form of a crystallizate.
priorityDate 2014-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5495042-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1838720-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4477390-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0225409-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010136566-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002105089-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0724576-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2434875-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0411941-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513201

Total number of triples: 25.